Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titletx.xpt (trial sets)
Expand
titleTX Domain


TRIAL ELEMENTS

RowSTUDYIDASSAYIDDOMAINETCDELEMENT



TETREATMTTreatment


Product, Smoking Regime (e.g. Traditional combustible, ENDS), Smoke Fraction, etc.

https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=969610#null

One study (Original sample of TK6 cells);  (6 rows in GT)

                 Assay (MNT) (ran on 10 tobacco products)
                      3 assay/test conditions; 
                             Treatment duration (2: ST, LT);
                             Presence of metabolic activation (2: presence, type)

                                    Concentrations of product (6 of these: 0, x, y, z,..., +CNTL);
                                    CytoTox % (3 different percentages from testing 1 portion of the original sample)
                                                4 MN counts conducted (on 4 different portions of original sample?)

EID (5 of these, Count1 - Count4 and Cytotox): with many TX Parm codes

Cytotox: RICC, RIC, RPD,  #cells

Assumption:  ASSAYID value of ALL means it applies to all assays in the study

Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123
TS1
GLPTYPGood Laboratory Practice TypeFDA
11123
TS1
STSTDTCStudy Start Date2007-12-30
13123
TS1
STITLEStudy TitleExample of a Crossover study in the Rat with 3 dose levels and 3 dosing periods
14123
TS1
SNDIGVERSEND Implementation Guide VersionTobacco IMPLEMENTATION GUIDE VERSION 1.0
15123
TS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-03-26
17123
TS1
SSPONSORSponsor OrganizationExample Sponsor Inc.
18123
TS1
SPREFIDSponsor's Study Reference ID
NOT APPLICABLE
19123
TS11TSTFNAMTest Facility NameExample Tox Lab Name
20123
TS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
21123
TS11TFCNTRYTest Facility CountryUSA
24123
TS11STDIRStudy DirectorDr. R. Smith
25123
TS1
TRTInvestigational Therapy or TreatmentDrug A
26123
TS12TRTVTreatment VehicleSaline
27123
TS12TRTVDESCTreatment Vehicle Structured Description100.46 %(w/v) ISOTONIC SODIUM CHLORIDE SOLUTION {UNII VR5Y7PDT5W}
28123
TS1
GLPFLGLP FlagY
29123MNTTS1
ASTDAssay StandardOECD Test No. 487 
30123MNTTS1
ASTDVAssay Standard Version2016-07-29
31123MNTTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
32123MNTTS1
SSSTYPStudy Sub TypeIn Vitro Micronucleus
33123MNTTS1
SPECIESSpeciesHomo Sapiens

123MNTTS1
??Test System?TK6 Lymphoblastoid Suspension Cells

123NRUTS1
ASTDAssay StandardNIH Publication No. 07-4519

123NRUTS1
ASTDVAssay Standard Version2006-11

123NRUTS1
SSTYPStudy Type


123NRUTS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red Uptake

123NRUTS1
SPECIESSpeciesHomo Sapiens

123NRUTS1
??Test System??Normal Human Keratinocyte
RowSTUDYIDASSAYIDDOMAINSETCDSETTXSEQTXPARMCDTXPARMTXVAL
11231MNTTXA

METACTMetabolic Activation+S9


1MNT
A

TRTDURTreatment DurationShort Term


1MNT
A

PRDCONCConcentration of product1250




1A

PRDCONCUConcentration Unitug/ml




1A1








A





















METACTMetabolic Activation-S9







TRTDURTreatment DurationShort Term







TRTDURTreatment DurationLong Term (or 2 parm codes, # and unit)







PRDCONCConcentration of product0







PRDCONCUConcentration Unitug/ml







ProductProduct Name








Smoking Regime








Smoke Fraction

...

Expand
titlegt.xpt (similar to LB)
RowSTUDYIDASSAYIDDOMAINTXCDGTSEQGTTESTCDGTTESTGTCELLEV
(cells evaluated)
GTORRESGTORRESUGTSTRESCGTSTRESNGTSTRESUGTDTCGTNOMDYGTELTMGTTPTREF
1123MNTGTA1RICC
13415.7%15.715.7%2022-05-25


2123MNTGTA2RCC
13413.0%13.013.0%2022-05-25


3123MNTGTA3RPD
1347.9%7.97.9%2022-05-25


4123MNTGTA4MNCELLSMicronucleated Cells326620Cells2020Cells2022-05-25


5
MNTGTA5MNCELLSMicronucleated Cells219017Cells1717Cells2022-05-25


6
MNTGTA6MNCELLSMicronucleated Cells725813Cells1313Cells2022-05-25


7
MNTGTA7AVGRELAverage Relative MN Frequency
0.66%0.660.66%2022-05-25


8
NRUGT













9

GT